Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1989-11-03
1991-05-14
Raymond, Richard L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514215, 514300, 540490, 540491, 540521, 546122, A61K 3155, C07D48704, C07D47104, C07D49804
Patent
active
050156381
ABSTRACT:
This invention relates to substituted pyridooxazinone and naphtheridone pyridones which are useful as cardiotonic agents for the treatment of congestive heart failure, to methods for increasing cardiac contractility using said compounds, and pharmaceutical compositions including the same.
REFERENCES:
patent: 3984405 (1976-10-01), Krapcho
patent: 4822794 (1989-04-01), Spada et al.
patent: 4866074 (1989-09-01), Spada et al.
Campbell Henry F.
Kuhla Donald E.
Spada Alfred P.
Studt William L.
Tucker Thomas
Barron Alexis
Nicholson James A.
Raymond Richard L.
Rhone-Poulenc Rorer Pharmaceuticals Inc.
Savitzky Martin F.
LandOfFree
Naphtheridinone- and pyridooxazinone-pyridone compounds, cardiot does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Naphtheridinone- and pyridooxazinone-pyridone compounds, cardiot, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Naphtheridinone- and pyridooxazinone-pyridone compounds, cardiot will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1648448